Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study Of Fenretinide In Patients With Hormone Refractory Prostate Cancer

NCT00077402 is registered in ClinicalTrials.gov with Cancer Therapeutics Research Group as lead sponsor.

NCT NCT00077402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00077402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study Of Fenretinide In Patients With Hormone Refractory Prostate Cancer
Lead sponsor
Cancer Therapeutics Research Group
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2003
Completion date
February 28, 2011
Enrollment
50 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer